aggressive fibromatosis desmoid tumor rare condition desmoid tumors type fibromatosis related sarcoma though without ability spread throughout body metastasize tumors arise cells called fibroblasts found throughout body provide structural support protection vital organs play critical role wound healing tumors tend occur women thirties occur anyone age either relatively slowgrowing malignant however aggressive fibromatosis locally aggressive cause lifethreatening problems even death tumors compress vital organs intestines kidneys lungs blood vessels nerves condition rarely fatal cases sporadic associated familial adenomatous polyposis fap approximately individuals gardners syndrome type fap extracolonic features desmoid world health organization reclassified desmoid tumors termed desmoidtype fibromatosis specific type tumor category intermediate locally aggressive fibroblastic myofibroblastic histologically resemble lowgrade locally aggressive tend recur even complete resection condition characterized variable often unpredictable clinical tendency recurrence setting prior surgery one study twothirds patients desmoid tumors history prior abdominal condition chronic may condition first described john macfarlane desmoid used johannes peter müller comes greek desmos band tendonlike describing tumors term found broad acceptance next several decades georg ledderhose c pfeiffer compiled reported number cases reaching early ralph w nichols first described correlation familial adenomatous polyposis fap desmoid arthur purdy stout coined term fibromatosis name congenital generalized fibromatosis describing myofibromatosis wnt signaling pathway alterations likely cause desmoid tumor mutations discovered betacatenin encoding gene tumorsuppressing apc gene affect wnt pathway study desmoid tumors lacking mutations found almost may mutations affect wntβcatenin pathway suggesting near universal relationship desmoid tumors wnt majority cases sporadic involve three distinct mutations identified mutation associated high risk apc mutations affect fap patients make smaller percentage sporadic disease tendency occur pregnancy exposure higher estrogen levels suggesting hormonal one study noted formation desmoid tumors guinea pigs prolonged estrogen factors include trauma risk factors desmoid disease amongst fap patients include female sex apc mutation positive family history history previous abdominal incidence desmoid tumors per million per constitute tumors less softtissue tumors primary age range peak years old females males retrospective multiinstitutional analysis patients found median age female children sex disparity commonly affected around years biopsy always indicated definitive method determine nature diagnosis may difficult part due use core needle biopsy open similarities among bland spindlecell lesions lead large number possibilities diagnosis including fibroblastic sarcomas gardner fibroma scar tissue keloids superficial fibromatosis nodular fasciitis myofibroma collagenous fibroma gastrointestinal stromal tumor solitary fibrous tumor conditions conditions may therefore also incorrectly diagnosed desmoid tumors cases one desmoid tumors may desmoid tumors occur almost anywhere classified extraabdominal abdominal wall intraabdominal last common patients cases occur mesentery abdominal wall one study shown extraabdominal tumors making cases abdominal tumors mesenteric though statistics pregnancyrelated tumors typically arise abdominal tumors located intraabdominally head neck highest risk mortality due proximity vital one analysis shown median tumor size cm though metastasis occur tumors may cases multifocal several located body apc mutation significant risk factor intraabdominal desmoid development amongst fap fap patients presenting abdominal wall desmoid preoperatively increased risk developing intraabdominal desmoid desmoid tumors breast rare constituting extraabdominal cases breast although benign mimic breast cancer physical examination mammography breast ultrasound also locally invasive even though occur sporadically also seen part gardners syndrome cases occur patients previously breast high index suspicion thorough triple examination protocol necessary detect rare lesions like desmoid tumor masquerade breast carcinoma desmoid tumor breast may present difficulty diagnosis especially imaging studies conclusive suggest ominous may arise chest wall breast desmoid tumors may occur head neck commonly among children tend aggressive extraabdominal locations tumors constitute extraabdominal standard staging system desmoid tumors fall cancer staging systems condition characterized variable often unpredictable clinical often considered potential death however tumors may grow regress remain management lesions complex main problem high rates recurrence particularly fapassociated disease recurrence rates general vary conversely intraabdominal fibromatosis without evidence fap although extensive surgery may still required local symptoms risk recurrence appears patients desmoid tumors evaluated multidisciplinary team surgeons medical oncologists radiation oncologists geneticists treated desmoid tumor experts typically softtissue sarcoma global consensus paper desmoid treatment notes summary clearly patients need referred centers experience desmoid tumors dt minimize risk active surveillance avoid unnecessarily debilitating mutilating surgery possibly needed surgery surgeons without significant experience management dt strongly nirogacestat selective gamma secretase inhibitor approved medical use united states november first medication approved us food drug administration fda treatment desmoid phase trial another selective gamma secretase inhibitor also ongoing begun drug granted orphan drug status surgery standard treatment desmoid tumors early due conditions unpredictability conservative management watchful waiting since become common due potential impacts surgical interventions clear medical groups including european organization research treatment cancer soft tissue bone sarcoma group european society medical oncology immediate surgical resection longer firstline treatment particularly asymptomatic complete removal always possible due tumors infiltrative nature tendrillike advanced recurring rapidly progressing cases treatment may consist complete surgical removal radiation therapy antiestrogens eg tamoxifen nonsteroidal antiinflammatory drugs nsaids chemotherapy ablation cold heat ultrasound treatment oral tyrosine kinase inhibitor drugs eg imatinib sorafenib pazopanib shows promising success radiation therapy surgery may improve despite conditions hormonal link antihormonal therapies appear work small subset intestinal transplant treatment option patients complicated desmoid tumor involving mesenteric root intestinal failure resulting tumor prior mri ct imaging scans commonly used though desmoid tumors metastasize invasiveness may lead pain loss function restricted movement chronic pain issue many patients may pressure vital organs deformity may economic burden treatment may significant surgery costs estimated us tumors may misdiagnosed due rarity lack knowledge patients may initially given poor prognoses due misdiagnosis conditions malignant patients may need visit multiple healthcare providers receive diagnosis causing delay care patients may experience issues including anxiety fatigue trouble sleeping level emotional distress compared patients sarcoma also malignant connective tissue lack knowledge healthcare providers information available patients others also cited specific instruments determine healthrelated quality life impacts desmoid patients gounderdesmoid tumor research foundation dtrf desmoid symptomimpact scale goddess desmoidtype fibromatosis quality life questionnaire dtfqol developed rare diseases specific code international classification october specific codes desmoid tumors included united states diagnosis code system request desmoid tumor research subcategory neoplasm uncertain behavior connective soft tissue created specific desmoid tumors occur dogs primarily head infrequently horses case also observed httpsenwikipediaorgwikiaggressivefibromatosis